Animal models of breast cancer: Experimental design and their use in nutrition and psychosocial research

Breast Cancer Research and Treatment

Volumn 46, Issue 2-3, 1997, Pages 117-133

  Clarke, Robert ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

AIN76; AIN93; Animal models; Breast cancer; Cell lines; DMBA; NMU

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ISOFLAVONOID; METHYLNITROSOUREA; RETINOID; TERPENE;

ANIMAL MODEL; BREAST CANCER; CALORIC RESTRICTION; CANCER MODEL; EXERCISE; FAT INTAKE; LIFESTYLE; METHODOLOGY; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; TUMOR GROWTH;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RESEARCH DESIGN;

EID: 0031457952     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005916627972     Document Type: Review

References (102)

1. Clarke R: Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 39:1-6, 1996
2. Carroll KK, Khor HT: Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol 10:308-353, 1975
3. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yaun J-M, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, Toniolo P, Shunzhang Y: Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 82:561-569, 1990
4. Hilakivi-Clarke LA, Rowland J, Clarke R, Lippman ME: Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat 29:141-160, 1993
5. Hilakivi-Clarke LA: Estrogen-regulated non-reproductive behaviors and breast cancer risk: Animal models and human studies. Breast Cancer Res Treat 46:143-159, 1997
6. Thompson HJ: Effects of physical activity and exercise on experimentally-induced mammary carcinogenesis. Breast Cancer Res Treat 46:135-141, 1997
7. Kritchevsky D: Caloric restriction and experimental mammary carcinogenesis. Breast Cancer Res Treat 46:161-167, 1997
8. Barnes S: The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 46:169-179, 1997 1997
9. Witte JS, Ursin G, Siemiatycki J, Thompson DW, Paganini-Hill A, Haile RW: Diet and premenopausal bilateral breast cancer: a case control study. Breast Cancer Res Treat 42:243-251, 1997
10. Hirohato T, Shigematsu T, Nomura AMY, Nomura Y, Horie A, Hirohato I: Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69:187-190, 1985
11. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Dietary effects on breast-cancer risk in Singapore. Lancet 337:1197-1200, 1991
12. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870, 1997
13. Wolbach SB, Howe PR: Vitamin A deficiency in the guinea-pig. Arch Pathol 5:239-253, 1928
14. Willett WC, Hunter DJ: Vitamin A and cancers of the breast, large bowel and prostate: epidemiologic evidence. Nutr Rev 52:S53-S59, 1994
15. Moon RC, Constantinou A: Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Breast Cancer Res Treat 46:181-189, 1997
16. Crowell PL: Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat 46:191-197, 1997
17. Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm A, Graham S, Howe GR, Kushi LH, Marshall JR, McDermott A, Miller AB, Speizer FE, Wolk A, Yaun S-S, Willett WC: Cohort studies of fat intake and risk of breast cancer: a pooled analysis. N Engl J Med 334:356-361, 1996
18. Howe GR, Friedenreich CM, Jain M, Miller AB: A cohort study of fat intake and risk of breast cancer. J Natl Cancer Inst 83:336-340, 1991
19. Prentice RL, Pepe M, Self SG: Dietary fat and breast cancer: a quantitative assessment of the epidemiological literature and a discussion of methodological issues. Cancer Res 49:3147-3156, 1989
20. Prentice RL: Measurement error and results from analytic epidemiology: dietary fat and breast cancer. J Natl Cancer Inst 88:1738-1747, 1996
21. Willett WC: Fat, energy and breast cancer. J Nutr 127:921s-923s, 1997
22. Hilakivi-Clarke LA: Mechanisms of high maternal fat intake during pregnancy on increased breast cancer risk in female rodent offspring. Breast Cancer Res Treat 46:199-214, 1997
23. Fay MP, Freedman LS: Meta-analyses of dietary fats and mammary neoplasms in rodent experiments. Breast Cancer Res Treat 46:215-223, 1997
24. Weed DL: Meta-analysis under the microscope. J Natl Cancer Inst 89:904-905, 1997
25. Trock BJ, Leonessa F, Clarke R: Multidrug resistance in breast cancer: a meta analysis of MDR1/ gp170 expression and its possible functional significance. J Natl Cancer Inst 89:917-931, 1997
26. Cave WT: Omega-3 polyunsaturated fatty acids in rodent models of breast cancer. Breast Cancer Res Treat 46:239-246, 1997
27. Rose DP, Connolly JM: Dietary fat and breast cancer metastasis by human tumor xenografts. Breast Cancer Res Treat 46:225-237, 1997
28. Rogers AE: Considerations in the design of studies of dietary influences on mammary carcinogenesis in rats and mice. Breast Cancer Res Treat 46:247-254, 1997
29. Rygaard K, Spang-Thomsen M: Quantitation and gompertzian analysis of tumor growth. Breast Cancer Res Treat 46:303-312, 1997
30. Hanfelt J: Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Res Treat 46:279-302, 1997
31. Clarke R: Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46:255-278, 1997
32. Schiffer SP: Animal welfare and colony management in cancer research. Breast Cancer Res Treat 46:313-331, 1997
33. Moulder JE: Effect of animal husbandry on misonidazole toxicity and pharmacokinetics. In: Kallman RF (ed) Rodent Tumor Models in Experimental Cancer Therapy. Pergamon Press, New York, 1987, pp 37-38
34. AIN Report: Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 107:1340-1348, 1977
35. AIN Report: Second Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 110:1726 1980
36. Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951, 1993
37. Thompson HJ: Diet, nutrition, and cancer: development of hypotheses and their evaluation in animal studies. Cancer Res 53:2442s-2445s, 1993
38. Sfakianos J, Coward L, Kirk M, Barnes S: Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260-1268, 1997
39. Hilakivi-Clarke LA, Onojafe I, Raygada M, Cho E, Clarke R, Lippman ME: Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. J Natl Cancer Inst 88:1821-1827, 1996
40. Liu J, Gilbert K, Parker HM, Haschek WM, Milner JA: Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite. Cancer Res 51:4613-4617, 1991
41. Beitz DC: Guidelines for describing diets for experimental animals. J Nutr 114:15-16, 1984
42. Russo J, Russo IH: Biology of disease: biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112-137, 1987
43. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Biology of disease: comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244-278, 1990
44. Russo J, Russo IH: Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39: 7-20, 1996
45. Russo J, Tay LK, Russo IH: Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5-73, 1982
46. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415-3443, 1985
47. Niazi SK, Hussain M: Disposition kinetics of 7,12-dimethylbenz(a)anthracene in rats. Biopharm Drug Disp 13:591-596, 1992
48. Lee SY, Walsh CT, Ng SF, Rogers AE: Toxicokinetics of 7,12-dimethylbenz(a)anthracene (DMBA) in rats fed high lard or control diets. J Nutr Growth Cancer 3:167-176, 1986
49. 14C by mammary parenchymal cells of the rat. Cancer Res 30:473-479, 1970
50. 14C-7,12-dimethylbenz[a]anthracene in rats fed diets varying in fat concentration. Pharmacology 39:89-97, 1989
51. Laher JM, Chernenko GA, Barrowman JA: Studies of the absorption and enterohepatic circulation of 7,12-dimethylbenz[a]anthracene in the rat. Can J Pharmacol Physiol 61:1368-1373, 1983
52. Phang JM, Poore CM, Lopaczynska J, Yeh GC: Flavonol-stimulated efflux of 7,12-dimethylbenz(a)-anthracene in multidrug-resislant breast cancer cells. Cancer Res 53:5977-5981, 1993
53. Fardel O, Ratanasavanh D, Loyer P, Ketterer B, Guillouzo A: Overexpression of the multidrug resistance gene product in adult hepatocytes during primary culture. Eur J Biochem 205:847-852, 1992
54. Pavelic ZP, Reising J, Pavelic L, Kelley DJ, Stambrook PJ, Gluckman JL: Detection of p-glycoprotein with four monoclonal antibodies in normal and tumor tissues. Arch Otolaryngol Head Neck Surg 119:753-757, 1993
55. Scala S, Saeki T, Lynch A, Salomon DS, Merino MJ, Bates SE: Coexpression of TGFα, epidermal growth factor receptor, and P-glycoprotein in normal and benign breast tissues. Diagn Mol Pathol 4:136-142, 1994
56. Archuleta MM, Born JL, Montano RM, Burchiel SW: Covalent binding of 7,12-dimethylbenz[a]anthracene to lymphoid and nonlymphoid tissues following oral administration to B6C3F1 mice. Toxicol Appl Pharmacol 113:113-137, 1992
57. Walaszek Z, Hanausek-Walaszek M, Webb TE: Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4:6,3-dilactone, an in vivo β-glucuronidase inhibitor. Carcinogenesis 5:767-772, 1984
58. Levine WG: Hepatic uptake, metabolism, and biliary excretion of 7,12-dimethylbenzanthracene in the rat. Drug Metab Disp 2:169-177, 1974
59. Vater ST, Baldwin DM, Warshawsky D: Hepatic metabolism of 7,12-dimethylbenz(a)anthracene in male, female, and ovariectomized Sprague-Dawley rats. Cancer Res 51:492-498, 1991
60. Shou M, Korzekwa KR, Krausz KW, Buter JTM, Grogan J, Goldfarb I, Hardwick JP, Gonzales FJ, Gelboin HV: Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Mol Carcinogenesis 17:241-249, 1996
61. Tamulski TS, Morreal CE, Dao TL: Comparative metabolism of 7,12-dimethylbenz(a)anthracene in liver and mammary tissue. Cancer Res 33:3117-3122, 1973
62. Flesher JW, Soekeni S, Kelley DR: Syntheses of metabolites of 7,12-dimethylbenz[a]anthracene. 4-hydroxy-7,12-dimethylbenz[a]anthracene, 7-hydroxymethyl-12-methylbenz[a]anthracene, their methyl ethers, and acetoxy derivatives. J Med Chem 10: 932-936, 1967
63. Falany CN, Wheeler J, Coward L, Keehan D, Falany JL, Barnes S: Bioactivation of 7-hydroxymethyl-12-methylbenz[a]anthracene by rat liver bile acid sulfotransferase I. J Biochem Toxicol 7:241-248, 1992
64. Surh Y-J, Liem A, Miller EC, Miller JA: Age- and sex-related differences in activation of the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene to an electrophilic sulfuric acid ester metabolite in rats. Biochem Pharmacol 41:213-221, 1991
65. Morrison VM, Burnett AK, Craft JA: Metabolism of 7,12-dimethylbenz[a]anthracene in hepatic microsomal membranes from rats treated with isoenzyme-selective inducers of cytochromes P450. Biochem Pharmacol 41:1505-1512, 1991
66. O'Dowd JJ, Burnett AK: The distribution of DMBA and its dihydrodiols in tissues of control and Sudan-III-treated Long-Evans rats after the injection (i.v.) in vivo of a leukaemogenic dose of the hydrocarbon. Carcinogenesis 9:29-35, 1988
67. Hatakeyama S, Hayasaki Y, Masuda M, Kazusaka A, Fujita S: Paradoxical effect of Sudan III on the in vivo and in vitro genotoxicity elicited by 7,12-dimethylbenz(a)anthracene. J Biochem Toxicol 10: 143-149, 1995
68. Cai Y, Baer-Dubowska W, Ashwood-Smith M, DiGiovanni J: Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo-[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes. Carcinogenesis 18:215-222, 1997
69. Budroe JD, Schol JG, Shaddock JG, Casciano DA: Inhibition of 7,12-dimethylbenz[a]anthracene-induced genotoxicity in chinese hamster ovary cells by retinol and retinoic acid. Carcinogenesis 9:1307-1311, 1988
70. Grubbs CJ, Eto I, Juliana MM, Hardin JM, Whitaker LM: Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Anticancer Res 10:661-666, 1990
71. Singletary KW, Milner JA: Influence of prior dietary protein intake on metabolism, DNA binding and adduct formation of 7,12-dimethylbenz[a]anthracene in isolated rat mammary epithelial cells. J Nutr 117:587-592, 1987
72. Singletary KW: Effect of butylated hydroxytoluene on the in vivo distribution, metabolism and DNA-binding of 7,12-dimethylbenz[a]anthracene. Cancer Lett 49:187-193, 1990
73. Ginsberg GL, Atherholt TB: DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo-(a)pyrene or the diol-epoxide. Cancer Res 50:1189-1194, 1990
74. Schwartz AG, Tannen RH: Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis 2:1335-1337, 1981
75. Falany JL, Falany CN: Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56:1551-1555, 1996
76. Surh Y-J, Lai C-C, Miller JA, Miller EC: Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxy-12-methylbenz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice. Biochem Biophys Res Commun 144: 576-582, 1987
77. Roche CJ, Zinger D, Geacintov NE: Enhancement of stability of 7β,8α,-dihydroxy-9α-epoxybenzo[a]pyrene by complex formation with serum albumin. Cancer Biochem Biophys 8:35-40, 1985
78. Rogers AE, Conner B, Boulanger C, Lee S: Mammary tumorigenesis in rats fed diets high in lard. Lipids 21:275-280, 1986
79. Isaacs JT: Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinoma. Cancer Res 48: 2204-2213, 1988
80. Sinha D, Dao TL: A direct mechanism of mammary carcinogenesis induced by 7,12-dimethylbenz[a]-anthracene. J Natl Cancer Inst 53:841-846, 1974
81. Richards J, Nandi S: Primary culture of rat mammary epithelial cells. II. Cytotoxic effects and metabolism of 7,12-dimethylbenz[a]anthracene and N-nitroso-N-methylurea. J Natl Cancer Inst 61:772-777, 1978
82. Chan P, Dao TL: Effects of dietary fat on age-dependent sensitivity to mammary carcinogenesis. Cancer Lett 18:245-249, 1983
83. Russo J, Russo I: Role of differentiation in the pathogenesis and prevention of breast cancer. Endocr Related Cancer 4:7-21, 1997
84. Moore CJ, Bachhuber AJ, Gould MN: Relationship of mammary tumor susceptibility, mammary cell mediated mutagenesis, and metabolism of polycyclic aromatic hydrocarbons in four types of rats. J Natl Cancer Inst 70:777-784, 1983
85. Hsu L-C, Kennan WS, Shepel LA, Jacob HJ, Szpirer C, Szpirer J, Lander ES, Gould MN: Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res 54:2765-2770, 1994
86. Isaacs JT: A mammary cancer suppressor gene and its site of action in the rat. Cancer Res 51:1591-1595, 1991
87. Slaga TJ, Gleason GL, DiGiovanni J, Sukumaran KB, Harvey RG: Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in mouse skin. Cancer Res 39:1934-1936, 1979
88. Heidelberger C: Chemical carcinogenesis. Adv Cancer Res 79-121, 1975
89. Jordan VC: Laboratory models of breast cancer to aid the elucidation of antiestrogenic action. J Lab Clin Med 109:267-277, 1987
90. McCormick DL, Adamowski CB, Fiks A, Moon RC: Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41:2690-2695, 1941
91. Zhang R, Haag JD, Gould MN: Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res 50: 4286-4290, 1990
92. Hilakivi-Clarke LA, Clarke R, Onojafe I, Raygada M, Cho E, Lippman ME: A high fat diet during pregnancy increases mammary epithelial density and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 94:9372-9377, 1997
93. Lasfargues EY, Ozzello L: Cultivation of human breast carcinomas. J Natl Cancer Inst 21:1131-1147, 1958
94. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamartiniere CA: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457, 1996
95. Verma AK, Johnson JA, Gould MN, Tanner MA: Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48:5754-5758, 1988
96. Cha RS, Thilly WG, Zarbl H: N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci USA 91:3749-3753, 1994
97. Jin Z, Houle B, Mikheev AM, Cha RS, Zarbl H: Alterations in H-ras-1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy. Cancer Res 56:4927-4935, 1996
98. Bennicke K, Conrad C, Sabroe S, Sorensen HT: Cigarette smoking and breast cancer. Br Med J 310: 1431-1433, 1995
99. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG: Cigarette smoking, N-acetyltransferase-2 genetic polymorphisms and breast cancer risk. J Am Med Assoc 276:1494-1501, 1996
100. Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, Bogdan G, Yuen J: Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5:399-403, 1996
101. Haile RW, Witte JS, Ursin G, Siemiatycki J, Bertoli J, Thompson DW, Paganini-Hill A: A case-control study of reproductive variables, alcohol, and smoking in premenopausal breast cancer. Breast Cancer Res Treat 37:49-56, 1996
102. Henderson IC, Shapiro CL: Adjuvant chemotherapy: an overview. In: Powles T, Smith IE (eds) Medical Management of Breast Cancer. Dunitz, London, 1991, pp 197-215